Latest news with #MASL
Business Wire
29-04-2025
- Health
- Business Wire
Niagen Bioscience Welcomes Dr. Pinchas Cohen to Scientific Advisory Board
LOS ANGELES--(BUSINESS WIRE)--Niagen Bioscience, Inc. (NASDAQ: NAGE) (formerly ChromaDex Corp.), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, is pleased to announce the appointment of Dr. Pinchas Cohen to its Scientific Advisory Board (SAB). Niagen Bioscience Welcomes Dr. Pinchas Cohen to Scientific Advisory Board Share Dr. Cohen is an internationally recognized leading expert in healthy aging and mitochondrial biology. He serves as Dean of the University of Southern California (USC) Leonard Davis School of Gerontology and is a Distinguished Professor of Gerontology, Medicine, and Biological Sciences. He is internationally renowned for pioneering the field of mitochondrial microproteins—newly discovered therapeutic targets for diseases of aging—and has published over 350 scientific papers in top scientific journals focusing on aging, dementia, cancer, diabetes, and the emerging science of microproteins. Rob Fried, CEO of Niagen Bioscience, remarked, "We are excited to learn from one of the great minds in mitochondrial and longevity research.' His most recent discoveries include the novel microproteins MOTS-c, SHLP, SHMOOSE, and MASL, which represent promising precision-medicine solutions for aging-related diseases in diverse populations. Dr. Cohen is also the founder of the Southern California Aging Research Consortium and two biotech companies, CohBar and MENTSH Therapeutics. His many accolades include the National Institutes of Health (NIH) Director's Transformative Research Award, the Glenn Award for Research in Biological Mechanisms of Aging, and election to both the American Association for the Advancement of Science (AAAS) and the National Academy of Inventors. Dr. Cohen expressed enthusiasm about the role, noting, "I am honored to join Niagen Bioscience's Scientific Advisory Board. The company's commitment to rigorous scientific research in the field of NAD+ and its impact on aging and metabolic health is truly commendable. I look forward to contributing to their ongoing efforts to enhance healthspan through innovative approaches." Niagen Bioscience remains dedicated to collaborating with leading scientists to further its mission of improving human health through cutting-edge NAD+ research. For additional information on Niagen Bioscience, visit About Niagen Bioscience: Niagen Bioscience, Inc. (NASDAQ: NAGE), formerly ChromaDex Corp., is the global leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. As a trusted pioneer of NAD+ discoveries, Niagen Bioscience™ is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. The Niagen Bioscience team, composed of world-renowned scientists, works with independent investigators from esteemed universities and research institutions around the globe to uncover the full potential of NAD+. A vital coenzyme found in every cell of the human body, NAD+ declines with age and exposure to everyday lifestyle stressors. NAD+ depletion is a key contributor to age-related changes in health and vitality. Distinguished by state-of-the-art laboratories, rigorous scientific and quality protocols, and collaborations with leading research institutions worldwide, Niagen Bioscience sets the gold standard for research, quality, and innovation. There's a better way to age. At the heart of its clinically proven product portfolio is Niagen® (patented nicotinamide riboside, or NR), the most efficient, well-researched, high-quality, and legal NAD+ booster available. Niagen powers the Company's consumer supplement, Tru Niagen®, the number one NAD+ boosting oral supplement in the United States† (available at and Niagen Plus™, featuring pharmaceutical-grade intravenous (IV) and injectable Niagen products ( Pharmaceutical-grade Niagen IV and injections are compounded and distributed by U.S. FDA-registered 503B outsourcing facilities and are available exclusively at clinics with a prescription. Niagen Bioscience's robust patent portfolio protects NR and other NAD+ precursors. Niagen Bioscience maintains a website at where copies of press releases, news, and financial information are regularly published. †Based on the top-selling dietary supplement brands by revenue per the largest U.S. e-commerce marketplace (as of 1/1/2024 - 12/31/2024). Forward Looking Statements: This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended. Statements that are not a description of historical facts constitute forward-looking statements and may often, but not always, be identified by the use of such words as "expects," "anticipates," "intends," "estimates," "plans," "potential," "possible," "probable," "believes," "seeks," "may," "will," "should," "could" or the negative of such terms or other similar expressions. Risks that contribute to the uncertain nature of these forward-looking statements include; our history of operating losses and need to obtain additional financing; the growth and profitability of our product sales; our ability to maintain sales, marketing and distribution capabilities; changing consumer perceptions of our products; our reliance on a single or limited number of third-party suppliers; and the risks and uncertainties associated with our business and financial condition. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, and actual results may differ materially from those suggested by these forward-looking statements. All forward-looking statements are qualified in their entirety by this cautionary statement and Niagen Bioscience undertakes no obligation to revise or update this release to reflect events or circumstances after the date hereof.
Associated Press
21-03-2025
- Sport
- Associated Press
TPT Global Tech Set to Broadcast First MASL Professional Indoor Soccer Game on Its VuMe Live Super App
First Game: Empire Strykers vs. San Diego Sockers - Sunday, March 23 at 7 PM EST SAN DIEGO, CA and ONTARIO, CA / ACCESS Newswire / March 21, 2025 / TPT Global Tech (OTC Pink:TPTW) and its subsidiary VüMe LLC ( are proud to announce the live broadcast of the final home game of the season for the Empire Strykers on the VüMe Live Super App, currently in beta. The Empire Strykers face off against rival San Diego Sockers on Sunday, March 23 at 7 PM EST at Toyota Arena. This game marks the kickoff of a one-year partnership between TPT Global Tech and the Major Arena Soccer League (MASL) to stream over 150 professional indoor soccer games across the U.S. and Mexico on VuMe Live. The app delivers full HD streaming and is available now in the Apple Store and Google Play Store. With teams like the San Diego Sockers, Empire Strykers, Baltimore Blast, and Chihuahua Savage, MASL represents the highest level of professional indoor soccer in North America. This new partnership brings MASL games to a global audience through VuMe's interactive streaming platform-featuring live chat, real-time engagement, and monetization tools for teams and sponsors. 'This partnership with VuMe allows us to take MASL global through an exciting, new digital platform,' said Jeff Burum, President of MASL. 'We're redefining how fans experience live sports,' added Stephen Thomas, CEO of TPT Global Tech. 'VuMe is more than just a streaming service-it's a next-gen fan engagement platform.' Catch the action live March 23 at 7 PM EST by downloading the VuMe Super App today. For more info, visit About TPT Global Tech, Inc. TPT Global Tech, Inc. is a technology holding company based in San Diego, California. It was formed as the successor of two U.S. corporations, Ally Pharma US and TPT Global, Inc. The Company operates in various sectors including media, telecommunications, Smart City Real Estate Development, and the launch of the first super App, VüMe Live technology platform. As a media content delivery hub, TPT Global Tech utilizes its own proprietary global digital media TV and telecommunications infrastructure platform. They offer software as a service (SaaS), technology platform as a service (PAAS), and cloud-based unified communication as a service (UCaaS) solutions to businesses worldwide. Their UCaaS services enable businesses of all sizes to access the latest voice, data, media, and collaboration features. Forward-Looking Statements This press release contains 'forward-looking statements' within the meaning of various provisions of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, commonly identified by such terms as 'believes,' 'looking ahead,' 'anticipates,' 'estimates' and other terms with similar meaning. Specifically, statements about the Company's plans for accelerated growth, improved profitability, future business partners, M&A activity, new service offerings, and pursuit of new markets are forward-looking statements. Although the company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Such forward-looking statements should not be construed as fact. The information contained in such statements is beyond the ability of the Company to control, and in many cases, the Company cannot predict what factors would cause results to differ materially from those indicated in such statements. All forward-looking statements in the press release are expressly qualified by these cautionary statements and by reference to the underlying assumptions.
Associated Press
14-03-2025
- Sport
- Associated Press
TPT Global Partners with Major Arena Soccer League (MASL) To Broadcast Games On VuMe Live Super App
VuMe Live expands into pro sports streaming with its first MASL game on March 23, 4 PM PST: Ontario Strykers vs. San Diego Sockers. SAN DIEGO, CA / ACCESS Newswire / March 14, 2025 / TPT Global Tech (OTC Pink:TPTW) and its subsidiary, VüMe LLC are excited to announce that the final home game of the season for the MASL Empire Strykers will be broadcast live on the VüMe Live SuperApp, currently in beta. The highly anticipated matchup against the San Diego Sockers will take place on March 23, 2025, at 4 pm PST from the Toyota Arena, allowing fans to experience the fast-paced action of Major Arena Soccer League (MASL) competition like never before. To watch the game live fans can download the VüMe Live Super App from the Apple Store or Google Play Store. This broadcast is part of TPT Global Tech's one-year strategic partnership with MASL to stream over 150 professional indoor soccer games across the U.S. and Mexico. VüMe has the capability to simultaneously stream all MASL games domestically and internationally, providing a seamless, Full HD sports viewing experience to fans worldwide. As MASL continues to grow in popularity, this collaboration marks a major step in expanding the league's digital presence and making professional indoor soccer more accessible. The Major Arena Soccer League (MASL) is the premier professional indoor soccer league in North America, featuring some of the most talented players in the sport. With teams spread across major cities in the United States and Mexico, MASL delivers an electrifying version of soccer that combines traditional skill with the intensity of a high-scoring, fast-paced indoor game. The league boasts some of the most storied franchises, including the San Diego Sockers, one of the most successful teams in indoor soccer history, and the Empire Strykers, an emerging force based in Ontario, California. Other major teams include the Baltimore Blast, Dallas Sidekicks, Kansas City Comets, St. Luis Ambush, Milwaukee Wave, and the two-time defending champion Chihuahua Savages in Mexico. Each of these teams represents a city with a passionate fan base, helping to grow the sport's popularity and reach. With VüMe's technology, MASL is expanding its reach beyond traditional broadcast methods and embracing the future of sports streaming. 'The MASL is excited to bring our brand of soccer to the world through the first Super App in the Western Hemisphere, VüMe,' said the Jeff Burum President of MASL. 'This partnership allows us to showcase the energy and skill of our league to a global audience while providing new revenue opportunities for our teams and sponsors.' 'We are thrilled to be the broadcast partner with the MASL and to begin by showcasing this exciting matchup on VüMe as we continue to redefine sports streaming,' said Stephen Thomas, CEO of TPT Global Tech. 'Our partnership with MASL allows us to bring fans closer to the game with interactive features, high-quality broadcasts, and a seamless viewing experience. This collaboration is not just about streaming-it's about creating a dynamic, engaged soccer community on a global scale.' As a next-generation digital platform, VüMe SuperApp, currently in beta, is designed to maximize fan engagement through high-definition streaming, real-time interactions, and immersive digital experiences. The platform features interactive tools such as live chats, polls, and social sharing to connect fans worldwide, as well as opportunities for advertising and merchandising, providing brands with innovative ways to reach MASL's growing audience. This partnership also aligns with TPT Global Tech's strategy to enhance shareholder value through content monetization, digital advertising, and sponsorship revenue, creating new engagement and business opportunities within the sports and entertainment space. Fans can watch the Empire Strykers take on the San Diego Sockers March 23, 2025 at 4pm PST live by downloading the VüMe SuperApp from the Apple Store or Google Play Store. For more details on the MASL and the VüMe's Super App, visit About TPT Global Tech, Inc. TPT Global Tech, Inc. is a technology holding company based in San Diego, California. It was formed as the successor of two U.S. corporations, Ally Pharma US and TPT Global, Inc. The Company operates in various sectors including media, telecommunications, Smart City Real Estate Development, and the launch of the first super App, VüMe Live technology platform. As a media content delivery hub, TPT Global Tech utilizes its own proprietary global digital media TV and telecommunications infrastructure platform. They offer software as a service (SaaS), technology platform as a service (PAAS), and cloud-based unified communication as a service (UCaaS) solutions to businesses worldwide. Their UCaaS services enable businesses of all sizes to access the latest voice, data, media, and collaboration features. Forward-Looking Statements This press release contains 'forward-looking statements' within the meaning of various provisions of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, commonly identified by such terms as 'believes,' 'looking ahead,' 'anticipates,' 'estimates' and other terms with similar meaning. Specifically, statements about the Company's plans for accelerated growth, improved profitability, future business partners, M&A activity, new service offerings, and pursuit of new markets are forward-looking statements. Although the company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Such forward-looking statements should not be construed as fact. The information contained in such statements is beyond the ability of the Company to control, and in many cases, the Company cannot predict what factors would cause results to differ materially from those indicated in such statements. All forward-looking statements in the press release are expressly qualified by these cautionary statements and by reference to the underlying assumptions.
